16th Apr 2026 A plain language summary looking at nivolumab + chemotherapy for Asian people with advanced/recurrent stomach or gastroesophageal cancer
16th Apr 2026 A plain language summary on the ELM-2 study: odronextamab for relapsed/refractory follicular lymphoma
25th Feb 2026 ADACCESS trial results comparing GP2017 (adalimumab biosimilar) and reference adalimumab treatments for plaque psoriasis: a plain language summary
25th Feb 2026 Plain language summary of medical event costs following medication change from apixaban to rivaroxaban in non-valvular atrial fibrillation patients across USA and Germany
25th Feb 2026 TASUKI-52 study of combination therapy using nivolumab, platinum chemotherapy, and bevacizumab for advanced or recurrent nonsquamous NSCLC: a plain language summary
25th Feb 2026 How the body handles lower-dose nilotinib tablet (Danziten™) versus capsule (Tasigna®): a plain language summary
25th Feb 2026 Treating agitation with brexpiprazole in different Alzheimer’s dementia patient subgroups: a plain language summary
25th Feb 2026 Plain language summary: DESTINY-Lung02 study of trastuzumab deruxtecan for HER2-mutant metastatic non-small-cell lung cancer
25th Feb 2026 Side-effect profile of brexpiprazole for agitation in people with Alzheimer’s dementia: a plain language summary
25th Feb 2026 Plain language summary of clinical research examining burosumab safety in young patients with X-linked hypophosphatemia
25th Feb 2026 Plain language summary of pegcetacoplan therapy in kidney transplant patients with C3G or primary IC-MPGN from the NOBLE study
25th Feb 2026 Plain language summary of sparsentan clinical trial findings in patients with focal segmental glomerulosclerosis
25th Feb 2026 Managing specific adverse effects of teclistamab in multiple myeloma patients: a plain language summary
25th Feb 2026 Long-term outcomes of atacicept therapy in IgA nephropathy patients: a plain language summary
25th Feb 2026 DESTINY-CRC02 trial results for trastuzumab deruxtecan in HER2-positive advanced colorectal cancer: a plain language summary
25th Feb 2026 Plain language summary: Focusing on life engagement as a treatment aim for adults experiencing major depressive disorder
22nd Jan 2026 Pain control using liposomal bupivacaine after knee replacement surgical procedures: a plain language summary
22nd Jan 2026 AMPECT study on nab-sirolimus therapy for advanced malignant perivascular epithelioid cell tumors: a plain language summary
22nd Jan 2026 Meeting care goals through ongoing botulinum toxin therapy for leg spasticity in adults: plain language summary
22nd Jan 2026 HARMONi-2 trial results comparing two treatments for PD-L1–positive non-small cell lung cancer: a plain language summary
22nd Jan 2026 Early results from the global X-Linked Hypophosphatemia (XLH) Registry: a plain language summary
22nd Jan 2026 Plain language summary: EASE research on Oleogel-S10 birch bark extract in epidermolysis bullosa care
22nd Jan 2026 Plain language summary: The Phase II ENGOT-OV60/GOG-3052/RAMP 201 study of dual avutometinib-defactinib therapy in recurrent low-grade serous ovarian cancer
22nd Jan 2026 EORTC 1333/PEACE-3 research on enzalutamide with or without radium-223 for advanced prostate cancer patients with bone metastases: a plain language summary
20th Jan 2026 Plain language summary: clinical outcomes of lonapegsomatropin treatment for children lacking growth hormone
20th Jan 2026 Plain language summary: One-year outcomes of vagus nerve stimulation therapy for Japanese patients with hard-to-treat epilepsy
28th Nov 2025 How patients and doctors view pulmonary hypertension treatment options: a plain language summary
28th Nov 2025 Apitegromab in young spinal muscular atrophy patients: SAPPHIRE study plain language summary
28th Nov 2025 Plain language summary: TROPiCS-04 study of sacituzumab govitecan in advanced urinary tract cancer
26th Nov 2025 Plain language summary: real-world tafamidis study in transthyretin amyloid cardiomyopathy (ATTR-CM) patients
28th Oct 2025 Vagus nerve stimulation therapy for severe childhood epilepsy over 2 years: plain language summary
28th Oct 2025 Plain language summary: AI-based monitoring of geographic atrophy treatment with pegcetacoplan
28th Oct 2025 ERICA study plain language summary: olanzapine for nausea in breast cancer patients on trastuzumab deruxtecan
28th Oct 2025 Plain language summary of POLARIS: real-world palbociclib effectiveness and life quality impact
28th Oct 2025 CEPHEUS study: daratumumab combination therapy for newly diagnosed multiple myeloma: plain language summary
28th Oct 2025 CheckMate 7FL trial: nivolumab versus placebo in estrogen-positive breast cancer treatment: plain language summary
